New England Research & Management’s AMN Healthcare AMN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4,265
| Closed | -$218K | – | 159 |
|
|
2024
Q2 | $218K | Sell |
4,265
-500
| -10% | -$25.6K | 0.1% | 160 |
|
|
2024
Q1 | $298K | Sell |
4,765
-525
| -10% | -$32.8K | 0.15% | 140 |
|
|
2023
Q4 | $396K | Sell |
5,290
-3,050
| -37% | -$228K | 0.21% | 123 |
|
|
2023
Q3 | $710K | Buy |
8,340
+400
| +5% | +$34.1K | 0.4% | 86 |
|
|
2023
Q2 | $866K | Sell |
7,940
-2,860
| -26% | -$312K | 0.5% | 71 |
|
|
2023
Q1 | $896K | Buy |
+10,800
| New | +$896K | 0.53% | 73 |
|
|
2020
Q3 | – | Sell |
-20,660
| Closed | -$935K | – | 136 |
|
|
2020
Q2 | $935K | Buy |
20,660
+12,855
| +165% | +$582K | 0.67% | 52 |
|
|
2020
Q1 | $451K | Sell |
7,805
-950
| -11% | -$54.9K | 0.39% | 85 |
|
|
2019
Q4 | $546K | Sell |
8,755
-200
| -2% | -$12.5K | 0.37% | 92 |
|
|
2019
Q3 | $515K | Sell |
8,955
-10,994
| -55% | -$632K | 0.37% | 92 |
|
|
2019
Q2 | $1.08M | Sell |
19,949
-31
| -0.2% | -$1.68K | 0.73% | 44 |
|
|
2019
Q1 | $941K | Buy |
+19,980
| New | +$941K | 0.64% | 57 |
|
|
2018
Q4 | – | Sell |
-23,147
| Closed | -$1.27M | – | 154 |
|
|
2018
Q3 | $1.27M | Buy |
23,147
+6,982
| +43% | +$382K | 0.82% | 44 |
|
|
2018
Q2 | $947K | Buy |
16,165
+9,652
| +148% | +$565K | 0.63% | 57 |
|
|
2018
Q1 | $370K | Sell |
6,513
-13,905
| -68% | -$790K | 0.25% | 126 |
|
|
2017
Q4 | $1.01M | Sell |
20,418
-4,889
| -19% | -$241K | 0.72% | 54 |
|
|
2017
Q3 | $1.16M | Buy |
25,307
+7,529
| +42% | +$344K | 0.85% | 48 |
|
|
2017
Q2 | $694K | Buy |
+17,778
| New | +$694K | 0.51% | 76 |
|
|
2015
Q3 | – | Sell |
-6,782
| Closed | -$214K | – | 162 |
|
|
2015
Q2 | $214K | Buy |
+6,782
| New | +$214K | 0.18% | 160 |
|